Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subjects: PER, MAT

Europe's Largest CBD Marketplace Alphagreen Strengthens Board With Senior Hires


- Board advisors Niel Marotta, Markus Hoffmann join Chairman Dr Patricio Stocker to scale Europe's largest CBD marketplace

- Alphagreen to leverage their significant production, distribution and retail experience

- Appointments follow first equity fundraise of £500k earlier this month

LONDON, April 8, 2020 /PRNewswire/ -- Alphagreen, Europe's largest consumer marketplace for certified cannabis (CBD, cannabidiol) products, has today announced the appointment of Niel Marotta and Markus Hoffmann as board advisors and Dr Patricio Stocker as Chairman. They will work directly with co-founder and CEO Alexej Pikovsky providing strategic counsel to scale the business globally.

In light of coronavirus, a surge in consumer demand for health and wellbeing products has seen a four-fold rise in visitors to Alphagreen and a 30% increase in sales this month. As people consider new ways and means to strengthen their immune systems, CDB products are proving popular in Europe. The recent fundraise, these new appointments and current trends put Alphagreen in prime position to underpin its market leading position, take further market share and look further afield in the CDB sector.

In 2015, Niel Marotta took his expertise in business development and capital markets and co-founded Indiva, a Canadian licensed producer of medical-grade cannabis. Today, they are a publicly traded company in Canada and the United States. Indiva produces premium pre-rolls, capsules and edibles. Prior to his role as President and Chief Executive Officer of Indiva, Niel spent two decades working in the finance industry in a variety of leadership roles

Niel Marotta commented: "The Alphagreen team have created a brilliant platform for producers of CBD products. Every producer in South and North America is looking for distribution channels in Europe. Alphagreen is well placed to enable access to one of the biggest consumer markets globally."

Markus Hoffmann, a lawyer by training, worked in private equity for several years covering green-tech, pharmaceuticals and consumer product companies. He has been active in the medical cannabis industry since 2015 spending time in New York at the Bronfman family office, a shareholder of the biggest European medical cannabis producer, Bedrocan. Most recently, he was part of the founding team of Jacana, a global licensed manufacturer of medical cannabis products looking to export medical cannabis into Europe.

Dr Patricio Stocker was previously Chairman, President and CEO of PharmaCielo, the world's largest licensed cannabis producer based in Toronto with Colombian operations. During his time there, he led the development of the Colombian cannabis industry and transformation by creating consumer-friendly, premium quality cannabis products that were ready-for-market. In 2019, he moved to Blueberries Medical Corporation as CEO, another producer of medicinal cannabis products, before his appointment to chairman of Alphagreen.

Before pivoting to the cannabis industry, Dr Stocker was an industry veteran of 20 years in the European and South American automotive industry, chiefly at Daimler. During his time there, he held various positions from country President and CEO for DaimlerChrysler Colombia to Head of Truck and Bus Division for Daimler Latin America.

The appointments come at an exciting time for Alphagreen as the business gears for growth and, separately, becomes a licensed manufacturer and wholesaler of cannabis products in Germany, making it one of the first companies selling to pharmacies across the country.

On the new appointment, Alexej Pikovsky, CEO and Co-Founder of Alphagreen commented: "Health and wellbeing are becoming more important than ever. Our platform has already enabled thousands of customers to discover high quality products and get them delivered to their homes. In preparing the business for the next phase of growth, we are delighted to welcome Niel, Markus and Patricio to the company. Their extensive experience of building businesses and expertise in the cannabis industry will provide just the perspective and guidance Alphagreen requires to consolidate the European market and expand further afield."

Dr Patricio Stocker, Chairman of Alphagreen commented: "Alphagreen is transforming the landscape of the cannabis product industry through a unique transparency for customers. Their focus on quality and the trust bond with consumers and suppliers means they are well placed for growth. Their game-changing and innovative attitude is refreshing. I look forward to working with the team in channeling their drive and ambition."

These appointments follow a £500k equity funding round at Alphagreen. Several tech angel investors took part in the funding round alongside the cannabis-focused investment company ENEXIS AB, which has backed several cannabis industry businesses including NOBL, Dragonfly Biosciences and Emmac Life Sciences.

Notes to the Editor

About Alphagreen Group

Alphagreen Group owns and runs Europe's largest consumer marketplace for certified cannabis (CBD, cannabidiol) products, Alphagreen.io. The UK-based marketplace has the largest number of high-quality products available in Europe. These high-quality non-psychoactive products (e.g. CBD) are from top global cannabis brands such as Provocan, Cibdol, Grass & Co, Wunder Workshop and Mr Nice. Several top vitamin brands such as Nature's Best, Healthspan and Naturelo have also been added to the marketplace to service customer demand and  provide thematic sets and bundles. 

Alphagreen Group also operates Alphagreen Med which is their 100% owned subsidiary in Dusseldorf looking to distribute medical cannabis to pharmacies in Germany.

The Alphagreen team has a unique combination of technology and finance professionals, as well as pharmacists. The team is supported by an advisory panel consisting former and current CEOs of the major cannabis companies in South and North America, as well as prominent technology entrepreneurs.

For further information please contact the Alphagreen press office: Bilal Mahmood on [email protected] or +44 (0) 20 3640-7759 and +44 (0) 771 400-7257.


These press releases may also interest you

at 07:35
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute...

at 07:35
dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced that it will present at the following investor conferences: 2024 Bloom Burton & Co....

at 07:30
Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly...

at 07:30
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024...

at 07:30
Ophthalmic lens technology leader HOYA Vision Care announced the launch of iD LifeStyle® 4 with 3D Binocular Visiontm technology, the newest progressive lens in its award-winning iD LifeStyle® family, now available to order across Canada. Building...



News published on and distributed by: